Sanofi and GlaxoSmithKline's potential Covid-19 vaccine triggered strong immune responses in all adult age groups in preliminary trials after an earlier setback, boosting optimism the shot may join the fight against the pandemic this year.
from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3w8wlrS
from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3w8wlrS
Comments
Post a Comment